• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov12
Autolus Therapeutics Reports Strong Q3 2025 Financials and Positive CAR T Therapy Clinical Data
16:33
Autolus Therapeutics released FY2025 Q3 earnings on November 12 Pre-Market (EST), actual revenue USD 21.19 M (forecast USD 21.31 M), actual EPS USD -0.2972 (forecast USD -0.2208)
14:30
Autolus Therapeutics released FY2025 9 Months Earnings on November 12 Pre-Market EST, with actual revenue of USD 51.1 M and EPS of USD -0.7436
14:30
Nov5
Autolus Therapeutics to Release FY2025 Q3 Earnings on November 12 Pre-Market EST, Forecast Revenue USD 21.31 M, EPS USD -0.229
00:20
Oct20
Gil Blum gives Autolus Therapeutics a Buy Rating
10:06
Aug12
Autolus Therapeutics released FY2025 Semi-Annual Earnings on August 12 Pre-Market EST, with actual revenue of USD 29.91 M and EPS of USD -0.4436
13:30

Schedules & Filings

Schedules
Filings
Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 21.19 M, Net Income -79.12 M, EPS -0.2972

Aug12
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 20.92 M, Net Income -47.92 M, EPS -0.18

May8
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 8.982 M, Net Income -70.16 M, EPS -0.2636

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MSOX
7.940
+107.85%
+4.120
YCBD
1.200
+90.17%
+0.569
THH
15.520
+57.72%
+5.680
WEED
25.325
+55.65%
+9.055
NCI
1.920
+54.84%
+0.680
CNBS
34.820
+54.57%
+12.293
MSOS
5.800
+54.26%
+2.040
CGC
1.740
+53.98%
+0.610
RYM
23.800
+47.73%
+7.690
TLRY
12.150
+44.13%
+3.720
View More